Plectin-related scapuloperoneal myopathy with treatment-responsive myasthenic syndrome

Neuropathol Appl Neurobiol. 2021 Feb;47(2):352-356. doi: 10.1111/nan.12652. Epub 2020 Aug 23.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Agents / therapeutic use
  • Adult
  • Ephedrine / therapeutic use
  • Frameshift Mutation
  • Humans
  • Male
  • Muscular Dystrophy, Emery-Dreifuss / complications*
  • Muscular Dystrophy, Emery-Dreifuss / genetics*
  • Muscular Dystrophy, Emery-Dreifuss / pathology
  • Myasthenic Syndromes, Congenital / drug therapy*
  • Myasthenic Syndromes, Congenital / genetics*
  • Plectin / genetics*

Substances

  • Adrenergic Agents
  • PLEC protein, human
  • Plectin
  • Ephedrine

Supplementary concepts

  • Scapuloperoneal myopathy